Lead Plaintiff Deadline: November 14, 2022
Please Upload related files below
Fill in below.
Looking for more?
Class A common stock during the period September 30, 2020 to August 5, 2022, including purchases pursuant and/or traceable to documents used in connection with the offer, sale, and direct listing of Palantir Class A common stock on the New York Stock Exchange beginning on or about September 30, 2020
(i) Palantir’s investments in marketable securities were having a significant negative impact on the Company’s earnings per share (“EPS”) results; (ii) Palantir overstated the sustainability of its government segment’s growth and revenues; (iii) Palantir was experiencing a significant slowdown in revenue growth, particularly among its government customers, despite ongoing global conflicts and market disruptions; (iv) as a result of all the foregoing, the Company was likely to miss consensus estimates for its first quarter 2022 EPS and second quarter 2022 sales outlook; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be included in the lawsuit, you must have incurred a loss on shares of Palantir purchased or acquired during the class period listed above and/or pursuant to the stock offering(s) referenced above.
If you suffered a loss in Palantir during the relevant time frame or pursuant to the relevant offering(s), you have until November 14, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.